Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.16 CAD | +16.18% | +8.59% | +48.36% |
04-23 | High Tide Up Almost 5% in US Premarket After Reporting Big Jump in Saturday Revenue | MT |
04-23 | High Tide Brief: Reporting Near $2 Million in Retail Sales on '4/20' | MT |
Summary
- Overall, and from a short-term perspective, the company presents an interesting fundamental situation.
Strengths
- Growth is a substantial asset for the company, as anticipated by dedicated analysts. Within the next three years, growth is estimated to reach 54% by 2026.
- The stock, which is currently worth 2024 to 0.47 times its sales, is clearly overvalued in comparison with peers.
- For the last 4 months, the company has been enjoying highly positive EPS revisions, which were frequently and significantly raised.
- Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
- The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
- Over the past twelve months, analysts' opinions have been strongly revised upwards.
Weaknesses
- As a percentage of sales and without taking into account depreciation and amortization, the company has relatively low margins.
- The company has insufficient levels of profitability.
- The valuation of the company is particularly high given the cash flows generated by its activity.
- For the last four months, the sales outlook for the coming years has been revised downwards. No recovery of the group's activities is yet foreseen.
- For the past year, analysts have significantly revised downwards their profit estimates.
- Prospects from analysts covering the stock are not consistent. Such dispersed sales estimates confirm the poor visibility into the group's activity.
- The price targets of analysts who cover the stock differ significantly. This implies difficulties in evaluating the company and its business.
- The company's earnings releases usually do not meet expectations.
Ratings chart - Surperformance
Sector: Drug Retailers
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+48.36% | 158M | - | ||
+41.56% | 2.88B | D+ | ||
+15.65% | 1.71B | - | ||
+118.82% | 626M | - | ||
+34.09% | 508M | - | ||
+8.64% | 105M | - | - | |
+57.30% | 57.54M | - | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
- Stock Market
- Equities
- HITI Stock
- Ratings High Tide Inc.